NASDAQ:ONTX
Delisted

Onconova Therapeutics Stock News

etoro logo Buy ONTX
*Your capital is at risk
$1.00
+0 (+0%)
At Close: Jul 01, 2024
The Bucks County firm's licensing deal with a Chinese drug company was voided after required payments were allegedly not made.
Rigosertib is partnered from agreements in 2019 with Knight Therapeutics for Canada, Specialised Therapeutics for Australia & New Zealand, and with Inceptua Medicines Access for a multi-country pre-ap
The Company  intends to use the net proceeds from the offering for working capital and general corporate purposes, including advancing preparations for a planned New Drug Application (NDA) filing to

Bucks County biopharm firm plans $10M stock sale

06:48pm, Thursday, 02'nd Jan 2020
The company also expects to file a new drug application for its lead new drug application later this year.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The offering is expected to close on or about January 3, 2019, subject to the satisfaction of customary closing cond
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE